Dr Jane Cooke Wright – whether you’ve heard of her or not, her research changed the path of oncology, paving the way for cancer treatment as we know it.READ MORE
A new study from Gunsoo Kim’s group at the Center for Neuroscience Imaging Research in Suwon suggests that the IC, a subcortical area of the brain known to centralize auditory signals, also processes motion information.
In this article, we explore why academia and research can be hard on an individual's mental health, speaking directly with the individuals and organizations that are championing mental health discussions in this space, and highlight areas where we're perhaps falling short and could improve.READ MORE
Exploring the Genetic Contribution to Incongruence Between an Individual's Internal Gender and External SexArticle
Technology Networks spoke with John Graham Theisen, MD, senior author of a recent study that explored the contribution of genetics to our gender identity.READ MORE
Academic publishing has proved stubbornly resistant to change, but preprint servers have started to make their mark. Technology Networks spoke to BiorXiv content lead Samantha Hindle to find out more about how preprints could shake up publishing and give scientists a new avenue through which to share their research.READ MORE
It is possible to improve symptoms in autistic children with a cheap generic drug, a new study shows.READ MORE
Internet memes are a bit like an inside joke you share with the entire internet.READ MORE
Research has contradicted longstanding theory around the origins of phantom limb pain (PLP), where amputees feel agony in limbs that have been amputated, persisting even decades after the removal. The research suggests that new interpretations of PLP are required to develop effective treatments.READ MORE
In this comment piece, Hubly Surgical CEO Casey Grage gives a perspective on her advancing career, which has seen her go from freshman to startup co-founder in just a few years.
Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.READ MORE